[
    {
        "molecule_name": "FXIIa",
        "protein_target_name": "FXIIa",
        "binding_metric": "Ki",
        "value": "<50",
        "unit": "pM",
        "raw_mentions": "These antibodies have high binding affinity to FXIIa (e.g., Ki<sup>app</sup>&lt;50 pM);"
    },
    {
        "molecule_name": "anti-FXIIa antibody",
        "protein_target_name": "FXIIa",
        "binding_metric": "Ki",
        "value": "1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5",
        "unit": "pM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the anti-FXIIa antibody described herein may have a Ki<sup>app </sup>value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope.\n* Differences in Ki<sup>app </sup>(e.g., for specificity or other comparisons) can be at least 1.5, 2, 3, 4, 5, 10, 15, 20, 37.5, 50, 70, 80, 91, 100, 500, 1000, 10,000 or 10<sup>5 </sup>fold.\n* The anti-FXIIa antibody as described herein can bind and inhibit the activity of FXIIa by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater)."
    },
    {
        "molecule_name": "anti-FXIIa antibody",
        "protein_target_name": "FXIIa",
        "binding_metric": "Kd",
        "value": "10^−5",
        "unit": "M",
        "raw_mentions": "The anti-FXIIa antibody described herein may have a binding affinity (K<sub>D</sub>) of at least 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10 </sup>M, or lower for the target antigen or antigenic epitope."
    },
    {
        "molecule_name": "anti-FXIIa antibody",
        "protein_target_name": "FXIIa",
        "binding_metric": "Kd",
        "value": "10^−6",
        "unit": "M",
        "raw_mentions": "The anti-FXIIa antibody described herein may have a binding affinity (K<sub>D</sub>) of at least 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10 </sup>M, or lower for the target antigen or antigenic epitope."
    },
    {
        "molecule_name": "anti-FXIIa antibody",
        "protein_target_name": "FXIIa",
        "binding_metric": "Kd",
        "value": "10^−7",
        "unit": "M",
        "raw_mentions": "The anti-FXIIa antibody described herein may have a binding affinity (K<sub>D</sub>) of at least 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10 </sup>M, or lower for the target antigen or antigenic epitope."
    },
    {
        "molecule_name": "anti-FXIIa antibody",
        "protein_target_name": "FXIIa",
        "binding_metric": "Kd",
        "value": "10^−8",
        "unit": "M",
        "raw_mentions": "The anti-FXIIa antibody described herein may have a binding affinity (K<sub>D</sub>) of at least 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10 </sup>M, or lower for the target antigen or antigenic epitope."
    },
    {
        "molecule_name": "anti-FXIIa antibody",
        "protein_target_name": "FXIIa",
        "binding_metric": "Kd",
        "value": "10^−9",
        "unit": "M",
        "raw_mentions": "The anti-FXIIa antibody described herein may have a binding affinity (K<sub>D</sub>) of at least 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10 </sup>M, or lower for the target antigen or antigenic epitope."
    },
    {
        "molecule_name": "anti-FXIIa antibody",
        "protein_target_name": "FXIIa",
        "binding_metric": "Kd",
        "value": "10^−10",
        "unit": "M",
        "raw_mentions": "The anti-FXIIa antibody described herein may have a binding affinity (K<sub>D</sub>) of at least 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10 </sup>M, or lower for the target antigen or antigenic epitope."
    },
    {
        "molecule_name": "Fab inhibitor",
        "protein_target_name": "FXIIa",
        "binding_metric": "Ki",
        "value": "800",
        "unit": "pM",
        "raw_mentions": "The selection produced a selective Fab inhibitor that specifically bound to the catalytic domain of FXIIa with a Ki<sup>app </sup>of 800 pM."
    },
    {
        "molecule_name": "M0192-H11",
        "protein_target_name": "human FXIIa",
        "binding_metric": "IC50",
        "value": "4.7+/−0.6",
        "unit": "pM",
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe inhibitory activities of clone M0192-H11 against human FXIIa, is shown in FIG. 21, and was found to be approximately 4.7+/−0.6 pM.\nM0191-E09313.70nM\nM0183-C03333.17nM\nM0184-F12383.74nM\nM0183-H08763.36nM\nM0182-D04963.13nM\nM0192-H111013.33nM\nM0292-D071153.11nM\nM0183-D081182.08nM\nM0192-F071253.00nM\nM0192-G031253.14nM\nM0310-C061352.46nM\nM0192-F011743.18nM\nM0191-A031762.88nM\nM0192-A011983.11nM\nM0191-H102163.81nM\nM0177-C122173.86nM\nM0184-B042693.76nM\nM0308-H032753.38nM\nM0192-D022793.30nM\nM0310-G072954.48nM\nM0192-F063043.49nM\nM0310-A043163.48nM\nM0310-F023191.86nM\nM0310-B093313.73nM\nM0310-G063533.18nM\nM0182-H01359N/AN/A\nM0178-A083813.26nM\nM0184-D014353.32nM\nM0177-A064584.08nM\nM0191-E044603.59nM\nM0191-H094633.61nM\nM0192-H044853.51nM\nM0192-A035143.34nM\nM0310-G087962.76nM\nM0192-G058523.38nM\nM0183-B1210043.06nM\nM0308-F0415703.29nM\nM0182-B04N/AN/AN/A"
    }
]